PDCD1 and neoplasm: Accordingly, we should perform immunohistochemical analysis of immune cells infiltrating tumor tissues and the interplay among PD-L1, Akt, and interferons in the tumor microenvironment of patients receiving immunotherapy that targets the PD-1/PD-L1 pathway to further elucidate the interactions between immune cells and tumor cells.